Literature DB >> 7927825

The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha.

D Palmović, I Kurelac, J Crnjaković-Palmović.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7927825     DOI： 10.1007/bf01716714

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  14 in total

1.  The pathology of hepatitis C.

Authors:  P J Scheuer; P Ashrafzadeh; S Sherlock; D Brown; G M Dusheiko
Journal:  Hepatology       Date:  1992-04       Impact factor: 17.425

2.  Interferon alfa-2b for decompensated liver disease caused by either chronic hepatitis B or C: preliminary results of a pilot study.

Authors:  M Dimopoulou; K Fafoutis; K Basiliou; J Ketikoglou; G Karvountzis
Journal:  Gut       Date:  1993       Impact factor: 23.059

3.  Initial results with recombinant interferon alfa-2b in patients with chronic hepatitis C: the United States experience.

Authors:  G L Davis
Journal:  Gut       Date:  1993       Impact factor: 23.059

4.  Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.

Authors:  N C Tassopoulos; M G Koutelou; G Papatheodoridis; H Polychronaki; I Delladetsima; T Giannikakis; A Todoulos; A Toliopoulos; A Hatzakis
Journal:  Gut       Date:  1993       Impact factor: 23.059

5.  Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b.

Authors:  J Genesca; J I Esteban; J Quer; L L Viladomiu; A Gonzalez; R Esteban; J Guardia
Journal:  Gut       Date:  1993       Impact factor: 23.059

6.  The declining risk of post-transfusion hepatitis C virus infection.

Authors:  J G Donahue; A Muñoz; P M Ness; D E Brown; D H Yawn; H A McAllister; B A Reitz; K E Nelson
Journal:  N Engl J Med       Date:  1992-08-06       Impact factor: 91.245

7.  Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non-A, non-B/type C hepatitis after transfusion.

Authors:  M Colombo; P Lampertico; M Rumi
Journal:  Gut       Date:  1993       Impact factor: 23.059

8.  Molecular cloning and heterogeneity of the human hepatitis C virus (HCV) genome.

Authors:  N Hayashi; H Higashi; K Kaminaka; H Sugimoto; M Esumi; K Komatsu; K Hayashi; M Sugitani; K Suzuki; O Tadao
Journal:  J Hepatol       Date:  1993       Impact factor: 25.083

9.  Three cases of posttransfusion hepatitis C treated with interferon-alpha. Confirmation of a carrier state by detection of hepatitis C virus RNA after interferon therapy.

Authors:  H Hagiwara; N Hayashi; A Kasahara; E Mita; T Takehara; H Fusamoto; T Kamada
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

10.  Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon.

Authors:  E de Alava; J Camps; J Pardo-Mindán; M García-Granero; M Muñoz; J Sola; M P Civeira; F Contreras; J J Vázquez; A Castilla
Journal:  Liver       Date:  1993-04
View more
  3 in total

1.  Interferon as treatment for acute hepatitis C. A meta-analysis.

Authors:  C Cammà; P Almasio; A Craxì
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Duration of HCV infection as a predictor of nonresponse to interferon.

Authors:  A Craxì; V Di Marco; C Cammà; P Almasio; S Magrin
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

3.  Natural interferon alpha treatment and interferon alpha receptor 2 levels in acute hepatitis C.

Authors:  Kazuyuki Ohata; Koji Yano; Hiroshi Yatsuhashi; Manabu Daikoku; Michiaki Koga; Katsumi Eguchi; Michitami Yano
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.